NIAID currently funds major research projects in Bangladesh, which are primarily focused on endemic diseases, such as cholera, amebiasis, and cryptosporidiosis; and on enteric pathogens, such as Vibrio cholerae and Entamoeba histolytica. Outbreaks and transmission of viruses, such as henipaviruses and enteroviruses, are also subjects of NIAID-funded research. One of the leading collaborating institutions is the International Centre for Diarrhoeal Disease Research in Dhaka, Bangladesh (ICDDRB).
Bangladesh is considered a low-prevalence country for AIDS, while the quality of tuberculosis (TB) control continues to improve, as stated in a World Health Organization (WHO) country profile. As in other countries in the region, cholera, dengue fever, malaria, Japanese encephalitis, yellow fever, and poliomyelitis are endemic to Bangladesh.
An umbrella agreement between the U.S. Government and the government of the People's Republic of Bangladesh on scientific and technological cooperation was signed on March 1, 2003, for purposes of strengthening bonds, sharing science and technology resources, and improving education for all citizens.
back to top
This information is not necessarily a complete list of NIAID research and NIAID-sponsored activities. It is intended to serve as an overview.
Last Updated October 15, 2012
Last Reviewed October 15, 2012